Axiom Investors LLC /De / AZNN
Axiom Investors LLC /De’s Astrazeneca PLC Position
Does Axiom Investors LLC /De own Astrazeneca PLC (AZNN)? Yes — 62.7K shares worth $12M (+0.14% of its 13F portfolio) as of Q1 2026, down from 444.5K shares the prior filed quarter.
Position Value
$12M
Q1 2026
Shares
62.7K
% of Portfolio
+0.14%
Quarters Held
16
currently held
Position History AZNN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 62.7K | $12M | +0.14% |
| Q3 2024 | 444.5K | $35M | +0.30% |
| Q3 2023 | 10.6K | $717,832 | +0.01% |
| Q2 2023 | 932.6K | $67M | +0.99% |
| Q1 2023 | 887.3K | $62M | +1.01% |
| Q4 2022 | 2.71M | $184M | +3.61% |
| Q3 2022 | 2.34M | $128M | +2.70% |
| Q2 2022 | 1.52M | $101M | +3.02% |
| Q3 2020 | 1.33M | $73M | +1.18% |
| Q2 2020 | 1.28M | $67M | +1.33% |
| Q1 2020 | 1.12M | $50M | +1.27% |
| Q4 2019 | 1.09M | $54M | +1.26% |
| Q3 2019 | 1.22M | $54M | +1.46% |
| Q2 2019 | 1.01M | $42M | +1.14% |
| Q1 2019 | 769.6K | $31M | +0.96% |
| Q4 2018 | 770.1K | $29M | +1.02% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Axiom Investors LLC /De’s full portfolio or all institutional holders of AZNN.